NPI: 1629158456 · BURLINGTON TOWNSHIP, NJ 08016 · Pediatrics Physician · NPI assigned 10/16/2006
Authorized official STONE, FABIAN controls 20+ related entities in our dataset. Read more
| Authorized Official | STONE, FABIAN (VP REVENUE CYCLE) |
| Parent Organization | CHOP CLINICAL ASSOCIATES, INC |
| NPI Enumeration Date | 10/16/2006 |
Other providers sharing the same authorized official: STONE, FABIAN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,104 | $323K |
| 2019 | 9,493 | $308K |
| 2020 | 6,982 | $163K |
| 2021 | 6,022 | $163K |
| 2022 | 6,825 | $196K |
| 2023 | 6,445 | $183K |
| 2024 | 3,473 | $115K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10,283 | 9,856 | $515K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,407 | 6,145 | $414K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7,335 | 7,236 | $161K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,297 | 1,294 | $82K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,235 | 1,234 | $77K |
| 92551 | 5,737 | 5,662 | $52K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 708 | 703 | $41K |
| 3008F | 5,900 | 5,820 | $36K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 343 | 338 | $23K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,442 | 1,439 | $20K |
| 99173 | 3,686 | 3,636 | $6K | |
| 90656 | 268 | 268 | $5K | |
| 90686 | 1,279 | 1,204 | $5K | |
| 96127 | 1,209 | 1,155 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 44 | 44 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 346 | 248 | $2K |
| 90461 | 142 | 142 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 95 | 95 | $668.91 |
| 0072A | 13 | 13 | $520.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 14 | 13 | $448.22 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 12 | 12 | $362.80 |
| 99177 | 87 | 86 | $299.60 | |
| 86580 | 83 | 83 | $294.84 | |
| 83655 | 12 | 12 | $180.00 | |
| 85018 | 56 | 56 | $83.15 | |
| 83718 | 14 | 14 | $54.47 | |
| 96161 | 149 | 148 | $52.78 | |
| 82465 | 14 | 14 | $28.99 | |
| 94760 | 720 | 657 | $16.92 | |
| 36416 | 141 | 141 | $4.77 | |
| 99000 | 273 | 272 | $0.00 |